HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Abnormal methylation of the promoter of CREM is broadly associated with male factor infertility and poor sperm quality but is improved in sperm selected by density gradient centrifugation.

AbstractOBJECTIVE:
To evaluate the methylation status of the promoter of CREM in patients with an abnormal protamine 1/protamine 2 (P1/P2) ratio or oligozoospermia. The effects of density gradient centrifugation and aging of males on CREM promoter methylation were also investigated.
DESIGN:
Experimental research study.
SETTING:
University andrology and research laboratory.
PATIENT(S):
Patients with abnormally low (n=24) and high (n=36) P1/P2 ratio; patients with oligozoospermia (n=32); and normozoospermic, fertile controls with normal P1/P2 ratio (n=40).
INTERVENTION(S):
The CpG methyaltion pattern of the promoter of CREM was examined using pyrosequencing.
MAIN OUTCOME MEASURE(S):
The percentage of methylation of 12 CpGs in the CREM promoter was compared between patients and fertile controls.
RESULT(S):
There was a significantly higher rate of methylation of CREM in patients with abnormal protamination and oligozoospermia compared with the control group. Sperm concentration, sperm motility, and normal head morphology were negatively correlated with the amount of CpG methylation. Sperm selected from the 90% gradient fraction exhibited less methylation than sperm from the 35% fraction.
CONCLUSION(S):
Patients with two types of male factor infertility display an increased abnormal methylation of CREM compared with control subjects. Increased methylation is associated with decreased semen quality, and sperm selected by density gradient centrifugation have less methylation. Further research is necessary to investigate whether epimutations can be found on other nonimprinted gene promoters as well.
AuthorsLaszlo Nanassy, Douglas T Carrell
JournalFertility and sterility (Fertil Steril) Vol. 95 Issue 7 Pg. 2310-4 (Jun 2011) ISSN: 1556-5653 [Electronic] United States
PMID21507395 (Publication Type: Journal Article)
CopyrightCopyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Biomarkers
  • CREM protein, human
  • PRM1 protein, human
  • Protamines
  • protamine 2
  • Cyclic AMP Response Element Modulator
Topics
  • Adult
  • Age Factors
  • Biomarkers (analysis)
  • Case-Control Studies
  • Centrifugation, Density Gradient
  • CpG Islands
  • Cyclic AMP Response Element Modulator (genetics)
  • DNA Methylation
  • Humans
  • Infertility, Male (genetics, metabolism, pathology)
  • Male
  • Oligospermia (genetics, metabolism, pathology)
  • Promoter Regions, Genetic
  • Protamines (analysis)
  • Sperm Count
  • Sperm Motility
  • Spermatozoa (chemistry, pathology)
  • Utah

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: